HIV prevention 2010: Where are we now and where are we going?

Current Opinion in HIV and AIDS

Volumn 5, Issue 4, 2010, Pages 265-268

  Cohen, Myron S ^a   Fidler, Sarah ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBODY; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ABSTINENCE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANTIBODY PRODUCTION; BEHAVIOR CHANGE; CHRONIC INFLAMMATION; CIRCUMCISION; CLINICAL TRIAL; CONDOM; CULTURAL FACTOR; EDITORIAL; EPIDEMIC; GENITAL SYSTEM; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFECTION PREVENTION; INFECTION RISK; MALE HOMOSEXUAL; MIXED INFECTION; MOLECULAR PHYLOGENY; MONONUCLEAR CELL; NONHUMAN; POPULATION RISK; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SKIN DEFECT; TREATMENT FAILURE; UGANDA; VIRUS LOAD; VIRUS REACTIVATION; VIRUS STRAIN; VIRUS TRANSMISSION;

AIDS VACCINES; ANTI-HIV AGENTS; BEHAVIOR CONTROL; CHEMOPREVENTION; DISEASE TRANSMISSION, INFECTIOUS; DISINFECTANTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; TIME FACTORS; VACCINATION;

EID: 77953582624     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32833acafa     Document Type: Editorial

References (38)

1. Cohen MS, Hellmann N, Levy JA, et al. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest 2008; 118:1244-1254.
2. Parkhurst JO. 'What worked?': the evidence challenges in determining the causes of HIV prevalence decline. AIDS Educ Prev 2008; 20:275-283.
3. McDaid LM, Hart GJ. Sexual risk behaviour for transmission of HIV in men who have sex with men: recent findings and potential interventions. Curr Opin HIV AIDS 2010; 5:311-315.
4. Muessig KE, Tucker JD, Wang BX, et al. HIV and syphilis among men who have sex with men in China: the time to act is now. Sex Transm Dis 2010. [Epub ahead of print]
5. Mayer KH, Mimiaga MJ, Safren SA. Out of the closet and into public health focus: HIV and STDs in men who have sex with men in middle income and resource-limited countries. Sex Transm Dis 2010. [Epub ahead of print]
6. Gilson L, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997; 350:1805-1809.
7. Cohen MS, Calibu P, Coates T. Prevention of the sexual transmission of the sexual transmission of HIV-1: preparing for success. J Int AIDS Soc 2008; 11:4.
8. Lingappa JR, Baeten JM, Wald A, et al. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010; 375:824-833.
9. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-439.
10. Fuchs J, Celum C, Wang J, et al. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J Infect Dis 2010; 201:1164-1168.
11. Zhu J, Hladik F, Woodward A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009; 15:886-892.
12. Templeton D. Male circumcision to reduce sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:344-349.
13. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217-223.
14. Keele B. Identifying and characterizing recently transmitted viruses. Curr Opin HIV AIDS 2010; 5:327-334.
15. McMichael AJ, Borrow P, Tomaras GD, et al. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 2010; 10:11-23.
16. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361:2209-2220.
17. Walker LM, Burton DR. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr Opin Immunol 2010. [Epub ahead of print]
18. Hessell AJ, Rakasz EG, Tehrani DM, et al. Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L. J Virol 2010; 84:1302-1313.
19. Barber TJ, Benn PD. Post exposure prophylaxis for HIV following sexual exposure. Curr Opin HIV AIDS 2010; 5:322-326.
20. Taylor S, Davies S. Antiretroviral drug concentrations in the male and female genital tract: implications for the sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:335-343.
21. Ramjee G. Microbicide research: current and future directions. Curr Opin HIV AIDS 2010; 5:316-321.
22. Kashuba AD, Dyer JR, Kramer LM, et al. Antiretroviral drug concentration in semen: implications for sexual transmission of HIV-1. Antimicrob Agents Chemother 1999; 43:1817-1826.
23. Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006; 20:85-92.
24. Sullivan P, Kayitenkore K, Chomba E, et al. Reduction of HIV transmission risk and high risk sex while prescribed ART: results from discordant couples in Rwanda and Zambia. In: 16th Conference on Retroviruses and Opportunistic Infections; Toronto, Canada; 2009.
25. Donnell D, Kiare J, Thomas K, et al. ART and risk of heterosexual HIV-1 transmission in HIV-1 serodiscordant African couples: a multinational prospective study. In: 17th Conference on Retroviruses and Opportunistic Infections (CROI); February 2010; abstract 136.
26. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373:48-57.
27. Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis (in press).
28. Smith RJ, Okano JT, Kahn JS, et al. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco. Science 2010; 327:697-701.
29. Das-Douglas M, Chu P, Santos GM, et al. Decreases in community viral load are associated with a reduction in new HIV diagnoses in San Francisco. In: 17th Conference on Retroviruses and Opportunistic Infections (CROI); February 2010; abstract 33.
30. Montaner J, Wood E, Kerr T, et al. Association of expanded HAART coverage with a decrease in new HIV diagnoses, particularly among injection drug users in British Columbia, Canada. In: 17th Conference on Retroviruses and Opportunistic Infections (CROI); February 2010; Aabstract 88LB.
31. LeVu S, Le Strat Y, Cazein F, et al. Population-based HIV incidence in France, 2003 to 2008. In: 17th Conference on Retroviruses and Opportunistic Infections (CROI); February 2010; abstract 36LB.
32. Jansen I, Geskus R, Davidovich U, et al. Increasing trend in HIV-1 incidence among young men who have sex with men in Amsterdam: a 25-year prospective cohort study. In: 17th Conference on Retroviruses and Opportunistic Infections (CROI); February 2010; abstract 35.
33. Cohen MS, Gay CL, Busch M, et al. The detection of acute HIV infection (in press).
34. Miller WC, Rosenber NE, Rutstein SE, Powers KA. The role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:277-282.
35. BrennerBG,Roger M, MoisiDD, et al. Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS 2008; 22:2509-2515.
36. Pilcher CD, Christopoulos KA, Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis 2010; 201 (Suppl 1): S7-S15.
37. Hamlyn E, Jones V, Kholoud P, Fidler S. Antiretroviral treatment of Primary HIV infection to reduce onward transmission Curr Opin HIV AIDS 2010; 5:283-290.
38. Pilcher CD, Joaki G, Hoffman IF, et al. Comparison of HIV-1 concentrations in blood and semen in acute and chronic infection. AIDS 2007; 21:1723-1730.